Press "esc" to clear
Go to Advanced Search

Showing results

110 of 5999
  • Embargo expired:
    22-Oct-2018 3:15 PM EDT

Article ID: 702538

Radiation/cisplatin combination established as standard of care for HPV-related head and neck cancer

American Society for Radiation Oncology (ASTRO)

Combinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial has now determined that cisplatin chemotherapy, combined with radiation therapy, produces the best results and should be considered the standard of care. Findings will be presented in a news briefing Tuesday at 3pm ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
22-Oct-2018 12:05 AM EDT
Gazit_NO_Watermark.jpg

Article ID: 702585

Scientists Awarded $8 Million to Develop Tissue Regeneration Therapy

Cedars-Sinai

A new method developed at Cedars-Sinai may revolutionize how severe injuries are treated by harnessing stem cells to regrow tissue damaged by major trauma, such as traffic accidents or war injuries.

Released:
22-Oct-2018 1:05 PM EDT
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702534

Combined therapy including pelvic lymph node radiation provides significant benefit for prostate cancer patients

American Society for Radiation Oncology (ASTRO)

The first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates, extending radiation therapy to the pelvic lymph nodes combined with adding short-term hormone therapy to standard treatment can extend the amount of time before their cancer spreads. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
22-Oct-2018 12:00 AM EDT
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702535

Radiation Therapy Outcomes Better for African-American Prostate Cancer Patients Than Caucasian Patients

American Society for Radiation Oncology (ASTRO)

While popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new analysis of genetic data from a large prospective registry and clinical data from several randomized trials indicates that African-American patients may have comparatively higher cure rates when treated with radiation therapy. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
21-Oct-2018 11:05 PM EDT
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702536

Men with low- and intermediate-risk prostate cancer can safely benefit from fewer, higher-dose radiation treatments

American Society for Radiation Oncology (ASTRO)

Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long-term, multi-institutional study. The study clears the way for patients who may wish to shorten their course of treatment without fear of increasing their risk for severe, adverse side effects. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
21-Oct-2018 11:05 PM EDT

Article ID: 702564

Urban and rural rates of childhood cancer survival the same, study finds

Washington University in St. Louis

Childhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new study from the Brown School at Washington University in St. Louis.“The widespread availability of public health insurance for children and adolescents and a nationwide network of pediatric cancer providers may explain this finding,” said Kimberly Johnson, associate professor and senior author of the study, “Rural/urban Residence and Childhood and Adolescent Cancer Survival in the United States,” published Oct.

Released:
22-Oct-2018 11:05 AM EDT
Ma_Li.jpg
  • Embargo expired:
    22-Oct-2018 11:00 AM EDT

Article ID: 702418

RNA Thought to Spread Cancer Shows Ability to Suppress Breast Cancer Metastasis

University of Texas M. D. Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RNA called metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) appears to suppress breast cancer metastasis in mice, suggesting a potential new area of therapeutic investigation. The findings, published in the Oct. 22 online issue of Nature Genetics, were surprising given that MALAT1, a long non-coding RNA (lncRNA), previously was described as a metastasis promoter.

Released:
21-Oct-2018 11:00 AM EDT
livermap_team.JPG

Article ID: 702542

Revealing the molecular mystery of human liver cells

University Health Network (UHN)

A map of the cells in the human liver has been created by University Health Network Transplant Program and University of Toronto researchers, revealing for the first time differences between individual cells at the molecular level which can have a profound impact on their behaviour in tissue, tumours and disease.

Released:
22-Oct-2018 8:05 AM EDT

Article ID: 702543

Abramson Cancer Center Receives $10.7 Million to Study CAR T Cells in Solid Tumors

Perelman School of Medicine at the University of Pennsylvania

new program project grant from the National Cancer Institute (NCI) will fund research by the Translational Center of Excellence for Lung Cancer Immunology at the Abramson Cancer Center of the University of Pennsylvania to improve the effectiveness of chimeric antigen receptor (CAR) T cell therapy at fighting solid tumors.

Released:
22-Oct-2018 8:05 AM EDT

Showing results

110 of 5999

Chat now!